These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 32258169)

  • 1. 20(S)-Ginsenoside Rg3 Protects Kidney from Diabetic Kidney Disease via Renal Inflammation Depression in Diabetic Rats.
    Zhou T; Sun L; Yang S; Lv Y; Cao Y; Gang X; Wang G
    J Diabetes Res; 2020; 2020():7152176. PubMed ID: 32258169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alleviative effects of 20(R)-Rg3 on HFD/STZ-induced diabetic nephropathy via MAPK/NF-κB signaling pathways in C57BL/6 mice.
    Li Y; Hou JG; Liu Z; Gong XJ; Hu JN; Wang YP; Liu WC; Lin XH; Wang Z; Li W
    J Ethnopharmacol; 2021 Mar; 267():113500. PubMed ID: 33091499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Korean red ginseng attenuates hyperglycemia-induced renal inflammation and fibrosis via accelerated autophagy and protects against diabetic kidney disease.
    Karunasagara S; Hong GL; Park SR; Lee NH; Jung DY; Kim TW; Jung JY
    J Ethnopharmacol; 2020 May; 254():112693. PubMed ID: 32112899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-135a regulates renal fibrosis in rats with diabetic kidney disease through the Notch pathway.
    Zhang LY; Wang Y; Yang YR; Shao JJ; Liang B
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1979-1987. PubMed ID: 32141566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ginsenoside Rg3 induces mesangial cells proliferation and attenuates apoptosis by miR-216a-5p/MAPK pathway in diabetic kidney disease.
    Chen Y; Peng Y; Li P; Jiang Y; Song D
    Aging (Albany NY); 2024 Jun; 16(11):9933-9943. PubMed ID: 38850526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Notoginsenoside R1 ameliorates podocyte injury in rats with diabetic nephropathy by activating the PI3K/Akt signaling pathway.
    Huang G; Lv J; Li T; Huai G; Li X; Xiang S; Wang L; Qin Z; Pang J; Zou B; Wang Y
    Int J Mol Med; 2016 Oct; 38(4):1179-89. PubMed ID: 27571993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of ginsenoside Rg5 against kidney injury via inhibition of NLRP3 inflammasome activation and the MAPK signaling pathway in high-fat diet/streptozotocin-induced diabetic mice.
    Zhu Y; Zhu C; Yang H; Deng J; Fan D
    Pharmacol Res; 2020 May; 155():104746. PubMed ID: 32156650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apigenin ameliorates streptozotocin-induced diabetic nephropathy in rats via MAPK-NF-κB-TNF-α and TGF-β1-MAPK-fibronectin pathways.
    Malik S; Suchal K; Khan SI; Bhatia J; Kishore K; Dinda AK; Arya DS
    Am J Physiol Renal Physiol; 2017 Aug; 313(2):F414-F422. PubMed ID: 28566504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of ginsenoside metabolite compound K against diabetic nephropathy by inhibiting NLRP3 inflammasome activation and NF-κB/p38 signaling pathway in high-fat diet/streptozotocin-induced diabetic mice.
    Song W; Wei L; Du Y; Wang Y; Jiang S
    Int Immunopharmacol; 2018 Oct; 63():227-238. PubMed ID: 30107367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minocycline Attenuates Kidney Injury in a Rat Model of Streptozotocin-Induced Diabetic Nephropathy.
    Yuan H; Zhang X; Zheng W; Zhou H; Zhang BY; Zhao D
    Biol Pharm Bull; 2016; 39(8):1231-7. PubMed ID: 27476934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astragaloside IV protects against diabetic nephropathy via activating eNOS in streptozotocin diabetes-induced rats.
    Fan Y; Fan H; Zhu B; Zhou Y; Liu Q; Li P
    BMC Complement Altern Med; 2019 Dec; 19(1):355. PubMed ID: 31805910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of catalpol on diabetic nephropathy in rats.
    Dong Z; Chen CX
    Phytomedicine; 2013 Aug; 20(11):1023-9. PubMed ID: 23746755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of ginsenoside Rg3 on lung injury in diabetic rats.
    Wang H; Wu W; Wang G; Xu W; Zhang F; Wu B; Tian Y
    J Cell Biochem; 2019 Mar; 120(3):3323-3330. PubMed ID: 30362612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mangiferin Alleviates Renal Interstitial Fibrosis in Streptozotocin-Induced Diabetic Mice through Regulating the PTEN/PI3K/Akt Signaling Pathway.
    Song Y; Liu W; Tang K; Zang J; Li D; Gao H
    J Diabetes Res; 2020; 2020():9481720. PubMed ID: 32076626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nepeta angustifolia C. Y. Wu improves renal injury in HFD/STZ-induced diabetic nephropathy and inhibits oxidative stress-induced apoptosis of mesangial cells.
    Huang S; Tan M; Guo F; Dong L; Liu Z; Yuan R; Dongzhi Z; Lee DS; Wang Y; Li B
    J Ethnopharmacol; 2020 Jun; 255():112771. PubMed ID: 32201300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nephro-protective effects of total triterpenoids from Psidium guajava leaves on type 2 diabetic rats].
    Kuang QT; Zhao JJ; Ye CL; Wang JR; Ye KH; Zhang XQ; Wang Y; Ye WC
    Zhong Yao Cai; 2012 Jan; 35(1):94-7. PubMed ID: 22734419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liraglutide protects from renal damage via Akt-mTOR pathway in rats with diabetic kidney disease.
    Liao TT; Zhao LB; Liu H; He RL; Wang YQ; Li J
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):117-125. PubMed ID: 31389583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-diabetic and renoprotective effects of Cassiae Semen extract in the streptozotocin-induced diabetic rats.
    Wang Q; Zhou J; Xiang Z; Tong Q; Pan J; Wan L; Chen J
    J Ethnopharmacol; 2019 Jul; 239():111904. PubMed ID: 31022564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of coenzyme Q10 alone and its combination with metformin on streptozotocin-nicotinamide-induced diabetic nephropathy in rats.
    Maheshwari RA; Balaraman R; Sen AK; Seth AK
    Indian J Pharmacol; 2014; 46(6):627-32. PubMed ID: 25538335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Huangkui capsule attenuates renal fibrosis in diabetic nephropathy rats through regulating oxidative stress and p38MAPK/Akt pathways, compared to α-lipoic acid.
    Mao ZM; Shen SM; Wan YG; Sun W; Chen HL; Huang MM; Yang JJ; Wu W; Tang HT; Tang RM
    J Ethnopharmacol; 2015 Sep; 173():256-65. PubMed ID: 26226437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.